276 related articles for article (PubMed ID: 26011295)
41. The impact of the COVID-19 pandemic on early termination of ophthalmology clinical trials: A cross-sectional analysis of ClinicalTrials.gov.
Kakkilaya A; Hooda K; Kalva P; Dasara H; Janssen C; Vasireddy S; Ahmed A; Khan S; Kooner K
SAGE Open Med; 2023; 11():20503121231216592. PubMed ID: 38078203
[TBL] [Abstract][Full Text] [Related]
42. Publication proportions for registered breast cancer trials: before and following the introduction of the ClinicalTrials.gov results database.
Asiimwe IG; Rumona D
Res Integr Peer Rev; 2016; 1():10. PubMed ID: 29451530
[TBL] [Abstract][Full Text] [Related]
43. A process evaluation accompanying an attempted randomized controlled trial of an evidence service for health system policymakers.
Wilson MG; Grimshaw JM; Haynes RB; Hanna SE; Raina P; Gruen R; Ouimet M; Lavis JN
Health Res Policy Syst; 2015 Dec; 13():78. PubMed ID: 26652277
[TBL] [Abstract][Full Text] [Related]
44. Funding source and primary outcome changes in clinical trials registered on ClinicalTrials.gov are associated with the reporting of a statistically significant primary outcome: a cross-sectional study.
Ramagopalan SV; Skingsley AP; Handunnetthi L; Magnus D; Klingel M; Pakpoor J; Goldacre B
F1000Res; 2015; 4():80. PubMed ID: 26069729
[TBL] [Abstract][Full Text] [Related]
45. From ClinicalTrials.gov trial registry to an analysis-ready database of clinical trial results.
Cepeda MS; Lobanov V; Berlin JA
Clin Trials; 2013 Apr; 10(2):347-8. PubMed ID: 23539114
[TBL] [Abstract][Full Text] [Related]
46. Assessing the readability of ClinicalTrials.gov.
Wu DT; Hanauer DA; Mei Q; Clark PM; An LC; Proulx J; Zeng QT; Vydiswaran VG; Collins-Thompson K; Zheng K
J Am Med Inform Assoc; 2016 Mar; 23(2):269-75. PubMed ID: 26269536
[TBL] [Abstract][Full Text] [Related]
47. The use and reporting of patient-reported outcomes in phase III breast cancer trials.
Brim RL; Pearson SD
Clin Trials; 2013 Apr; 10(2):243-9. PubMed ID: 23539108
[TBL] [Abstract][Full Text] [Related]
48. Gastroenterology Clinical Trials Transparency: An Analysis of Publication Rates From the ClinicalTrials.gov Database.
Garg S; Rizvi A; Wee D; Sreenivasan A; Suchman K; Thomas SL; Inamdar S; Trindade AJ
Am J Gastroenterol; 2022 Jan; 117(1):180-183. PubMed ID: 34534127
[TBL] [Abstract][Full Text] [Related]
49. Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands.
van den Bogert CA; Souverein PC; Brekelmans CTM; Janssen SWJ; Koëter GH; Leufkens HGM; Bouter LM
J Clin Epidemiol; 2017 Aug; 88():140-147. PubMed ID: 28487159
[TBL] [Abstract][Full Text] [Related]
50. Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve.
Filippi-Arriaga F; Boy RJ; Del Gobbo AD; Gallego AR
Eur J Clin Pharmacol; 2023 Feb; 79(2):249-256. PubMed ID: 36525040
[TBL] [Abstract][Full Text] [Related]
51. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
52. Pediatric Trials Run in India: An Analysis of Clinical Trials.gov 2006-2015.
Lorenzoni G; Comoretto RI; Ruffolo M; Azzolina D; Baldi I
Indian J Pediatr; 2019 Jan; 86(Suppl 1):10-14. PubMed ID: 30648225
[TBL] [Abstract][Full Text] [Related]
53. Issues in the registration of clinical trials.
Zarin DA; Ide NC; Tse T; Harlan WR; West JC; Lindberg DA
JAMA; 2007 May; 297(19):2112-20. PubMed ID: 17507347
[TBL] [Abstract][Full Text] [Related]
54. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
Roumiantseva D; Carini S; Sim I; Wagner TH
Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
[TBL] [Abstract][Full Text] [Related]
55. Data monitoring committees, interim analysis and early termination in paediatric trials.
Fernandes RM; van der Lee JH; Offringa M
Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
[TBL] [Abstract][Full Text] [Related]
56. Feasibility of Extracting Key Elements from ClinicalTrials.gov to Support Clinicians' Patient Care Decisions.
Kim H; Bian J; Mostafa J; Jonnalagadda S; Del Fiol G
AMIA Annu Symp Proc; 2016; 2016():705-714. PubMed ID: 28269867
[No Abstract] [Full Text] [Related]
57. Barriers to clinical trial recruitment in head and neck cancer.
Haddad RI; Chan AT; Vermorken JB
Oral Oncol; 2015 Mar; 51(3):203-11. PubMed ID: 25593017
[TBL] [Abstract][Full Text] [Related]
58. Clinical trial transparency in gastrointestinal endoscopy research.
Garg S; Rizvi A; Wee D; Rizvi Y; Rizvi F; Rizvi A; Thomas SL; Inamdar S; Trindade AJ
Endoscopy; 2023 Jan; 55(1):36-41. PubMed ID: 35584782
[TBL] [Abstract][Full Text] [Related]
59. Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years.
Pellat A; Boutron I; Ravaud P
Oncologist; 2022 Nov; 27(11):e849-e855. PubMed ID: 35983949
[TBL] [Abstract][Full Text] [Related]
60. Evolution of the Neurosurgeon's Role in Clinical Trials for Glioblastoma: A Systematic Overview of the Clinicaltrials.Gov Database.
Mansouri A; Beyn ME; Pancholi A; Chow CT; Wang R; Boutet A; Elias GJB; Germann J; Loh A; Voisin MR; Lozano AM; Chiocca EA; Vogelbaum MA; Zadeh G
Neurosurgery; 2021 Jul; 89(2):196-203. PubMed ID: 33989408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
